Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice
Charles D. Searles, David G. Harrison
Charles D. Searles, David G. Harrison
Published October 15, 1999
Citation Information: J Clin Invest. 1999;104(8):1013-1014. https://doi.org/10.1172/JCI8507.
View: Text | PDF
Commentary

The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice

  • Text
  • PDF
Abstract

Authors

Charles D. Searles, David G. Harrison

×

Total citations by year

Year: 2024 2023 2020 2018 2017 2012 2011 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 Total
Citations: 1 1 1 1 1 2 1 2 2 1 3 1 2 1 3 2 4 29
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (29)

Title and authors Publication Year
LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice
Munkhjargal U, Fukuda D, Maeda J, Hara T, Okamoto S, Bavuu O, Yamamoto T, Sata M
Journal of Atherosclerosis and Thrombosis 2024
The Link Between Heat Shock Proteins, Renin-Angiotensin System, and the Coagulation Cascade in the Pathogenesis of the Coronavirus-19 Disease.
Saha A, Ahmed S
Advances in experimental medicine and biology 2023
Snake venom‐derived bradykinin‐potentiating peptides: A promising therapy for COVID ‐19?
AS Gouda, B Mégarbane
Drug Development Research 2020
Combined Angiotensin Receptor–Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
RK Trivedi, DJ Polhemus, Z Li, D Yoo, H Koiwaya, A Scarborough, TT Goodchild, DJ Lefer
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2018
Beneficial effects of rosiglitazone and losartan combination in diabetic rats
H Ateyya, MA Nader, NA El-Sherbeeny
Canadian Journal of Physiology and Pharmacology 2017
The Angiotensin II Type 2 Receptor in Brain Functions: An Update
MO Guimond, N Gallo-Payet
International Journal of Hypertension 2012
How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?
MO Guimond, N Gallo-Payet
Frontiers in Endocrinology 2012
Heart Failure: A Companion to Braunwald's Heart Disease
A Diwan, GW Dorn
Heart Failure: A Companion to Braunwald's Heart Disease 2011
Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease
RS Deeb, BD Lamon, DP Hajjar
Current hypertension reviews 2009
Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study
T Sawada, H Yamada, B Dahlof, H Matsubara
European Heart Journal 2009
Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination on Nitric Oxide Bioavailability and Atherosclerotic Change in Watanabe Heritable Hyperlipidemic Rabbits
T IMANISHI, A KUROI, H IKEJIMA, K KOBAYASHI, Y MURAGAKI, S MOCHIZUKI, M GOTO, K YOSHIDA, T AKASAKA
Hypertension Research 2008
Effect of chronic inhibition of converting enzyme on proximal tubule acidification
PL Diaz-Sylvester, MC Fiori, SM Dieguez, AC Müller, ML Lopardo, CE Amorena
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2008
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes
2007
Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism
VD Colonna, S Fioretti, A Rigamonti, S Bonomo, B Manfredi, EE Muller, F Berti, G Rossoni
Journal of Hypertension 2006
Molecular Mechanisms in Hypertension
T Shimosawa, T Fujita, R Watson, S Supowit, D DiPette
Molecular Mechanisms in Hypertension: paracrine regulator of salt sensitivity and blood pressure 2006
Effects of Angiotensin II Type 1 Receptor Blockade on the Systemic Blood Nitric Oxide Dynamics in N.OMEGA.-Nitro-L-Arginine Methyl Ester-Treated Rats
Y KANEMATSU, K TSUCHIYA, H OHNISHI, Y MOTOBAYASHI, Y IZAWA, M ISHIHARA, K ISHIZAWA, S ABE, K KAWAZOE, T TAMAKI
Hypertension Research 2006
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in l-NAME-induced hypertensive rats
VD Colonna, A Rigamonti, S Fioretti, S Bonomo, B Manfredi, P Ferrario, M Bianchi, F Berti, EE Muller, G Rossoni
European Journal of Pharmacology 2005
Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man
JS Sim, C Farquharson, AD Struthers
Journal of Renin-Angiotensin-Aldosterone System 2004
Angiotensin Vol. I
T Unger, BA Schölkens
2004
Inflammation in early atherogenesis: impact of ACE inhibition
RD Caterina, C Manes
European Heart Journal Supplements 2003
Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria
KC Tan, WS Chow, VH Ai, KS Lam
Diabetes/Metabolism Research and Reviews 2002
ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors
AJ Turner, SR Tipnis, JL Guy, GI Rice, NM Hooper
Canadian Journal of Physiology and Pharmacology 2002
Progress in focus: recent advances in Histochemistry and Cell Biology
E Asan
Histochemistry and Cell Biology 2002
Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase
B Hornig, U Landmesser, C Kohler, D Ahlersmann, S Spiekermann, A Christoph, H Tatge, H Drexler
Circulation 2001
Mechanisms regulating angiotensin II responsiveness by the uteroplacental circulation
CR Rosenfeld
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2001
Update: Role of the angiotensin type-2 (AT2) receptor in blood pressure regulation
RM Carey, ZQ Wang, HM Siragy
Current Hypertension Reports 2000
Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation
RM Carey, ZQ Wang, HM Siragy
Current Hypertension Reports 2000
Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides
DJ Campbell
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] 2000
ACE inhibitors, angiotensin receptor antagonists and bradykinin
M Schachter
Journal of Renin-Angiotensin-Aldosterone System 2000

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts